대한의생명과학회지 (Biomedical Science Letters)

  • 제19권1호
  • /
  • Pages.9-16
  • /
  • 2013
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지

Characterization of Matrix Metalloproteinase Expression in Triglyceride Treated THP-1 Macrophages

  • Cho, Yoonjung (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Lim, Jaewon (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Lee, Dong Hyun (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Jung, Byung Chul (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Lee, Min Ho (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Jung, Dongju (Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University) ;
  • Kim, Yoon Suk (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Kim, Tae Ue (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Rhee, Ki-Jong (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
  • 투고 : 2013.02.14
  • 심사 : 2013.03.17
  • 발행 : 2013.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Elevated blood triglyceride (TG) levels correlate with development of atherosclerosis suggesting that TG may promote the development of this disease. During atherosclerosis, TG is taken up by tissue macrophages which result in dramatic changes in various secreted factors. One such factor is the family of matrix metalloproteases (MMP) which are involved in tissue remodeling during both physiological and pathological processes. In this study, we examined the MMP expression profile in PMA-differentiated THP-1 macrophages treated with TG. We found that TG-treated THP-1 macrophages showed decreased expression of MMP-3, MMP-7, MMP-8 and MMP-9 in a time- and dose-dependent manner. In contrast, expression of MMP-1, MMP-2, and MMP-10 remained relatively unchanged after TG treatment. In addition, we found that expression of select MMPs was affected by various inhibitors of signaling pathways. In particular, expression of MMP-3 was slightly recovered by cRAF and PLC signaling pathway inhibitors. These data suggests a possible role of MMPs in macrophages during TG-induced atherosclerosis.

키워드

참고문헌

  1. Adams LD, Geary RL, Li J, Rossini A, Schwartz SM. Expression profiling identifies smooth muscle cell diversity within human intima and plaque fibrous cap: loss of RGS5 distinguishes the cap. Arterioscler Thromb Vasc Biol. 2006. 26: 319-325.
  2. Amalinei C, Caruntu ID, Giusca SE, Balan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. 2010. 51: 215-228.
  3. Amorino GP, Hoover RL. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol. 1998. 152: 199-207.
  4. Armstrong C, Abilleira S, Sitzer M, Markus HS, Bevan S. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke. 2007. 38: 2895-2899. https://doi.org/10.1161/STROKEAHA.107.491696
  5. Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, Bourgoin P, Edwards DR, Yong VW. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain. 2003. 126: 2738-2749. https://doi.org/10.1093/brain/awg285
  6. Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010. 1803: 3-19. https://doi.org/10.1016/j.bbamcr.2009.07.004
  7. Geurian K, Pinson JB, Weart CW. The triglyceride connection in atherosclerosis. Ann Pharmacother. 1992. 26: 1109-1117. https://doi.org/10.1177/106002809202600913
  8. Hojilla CV, Mohammed FF, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer. 2003. 89: 1817-1821. https://doi.org/10.1038/sj.bjc.6601327
  9. Johnson JL. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther. 2007. 5: 265-282. https://doi.org/10.1586/14779072.5.2.265
  10. Kannel WB, Vasan RS. Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol. 2009. 24: 345-350. https://doi.org/10.1097/HCO.0b013e32832c1284
  11. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol. 2011. 31: 1506-1516. https://doi.org/10.1161/ATVBAHA.110.221127
  12. Lim J, Cho Y, Lee DH, Jung BC, Kang HS, Kim T-J, Rhee K-J, Kim TU, Kim YS. Upregulation of MMP is mediated by MEK1 activation during differentiation of monocyte into macrophage. J Exp Biomed Sci. 2012. 18: 104-111.
  13. Matias-Roman S, Galvez BG, Genis L, Yanez-Mo M, de la Rosa G, Sanchez-Mateos P, Sanchez-Madrid F, Arroyo AG. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood. 2005. 105: 3956-3964. https://doi.org/10.1182/blood-2004-06-2382
  14. Miyagawa J, Hanafusa T. Mechanism of atherosclerosis in diabetes: altered cytokine network in the vascular wall. Nihon Rinsho. 1999. 57: 601-606.
  15. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006. 69: 562-573. https://doi.org/10.1016/j.cardiores.2005.12.002
  16. Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol. 2008. 28: 2108-2114. https://doi.org/10.1161/ATVBAHA.108.173898
  17. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of nflammation and innate immunity. Nat Rev Immunol. 2004. 4: 617-629. https://doi.org/10.1038/nri1418
  18. Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neuroscience. 2010. 30: 15337-15357. https://doi.org/10.1523/JNEUROSCI.3467-10.2010
  19. Ross R. Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant Proc. 1993. 25: 2041-2043.
  20. Schafers M, Schober O, Hermann S. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques. J Nucl Med. 2010. 51: 663-666. https://doi.org/10.2967/jnumed.109.065698
  21. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999. 31: 23-37. https://doi.org/10.1006/jmcc.1998.0841
  22. Souza HP, Frediani D, Cobra AL, Moretti AI, Jurado MC, Fernandes TR, Cardounel AJ, Zweier JL, Tostes RC. Angiotensin II modulates CD40 expression in vascular smooth muscle cells. Clin Sci (Lond). 2009. 116: 423-431. https://doi.org/10.1042/CS20080155
  23. Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol. 2008. 19: 355-361. https://doi.org/10.1097/MOL.0b013e328304b63c
  24. Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid Redox Signal. 2009. 11: 2333-2339. https://doi.org/10.1089/ars.2009.2469
  25. Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol. 2009. 86: 1089-1095. https://doi.org/10.1189/jlb.0209115
  26. Valdivielso P, Sanchez-Chaparro MA, Calvo-Bonacho E, Cabrera-Sierra M, Sainz-Gutierrez JC, Fernandez-Labandera C, Fernandez-Meseguer A, Quevedo-Aguado L, Moraga MR, Galvez-Moraleda A, Gonzalez-Quintela A, Roman-Garcia J. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis. 2009. 207: 573-578. https://doi.org/10.1016/j.atherosclerosis.2009.05.024